For treatment of: Rovamycinum It is used sinusitis, pharyngitis, tonsillitis, pneumonia, bronchitis, bacterial odontogenic infections, acute chronic and recurrent infections of the genitourinary system.Rovamycinum spiramycin
- For the treatment of organs: oral cavity, respiratory system, skin.
- Appointment: sinusitis, pharyngitis, tonsillitis, pneumonia, bronchitis, bacterial odontogenic infections, acute chronic and recurrent infections of the genitourinary system.
- Indications for use:
Infectious and inflammatory diseases caused by microorganisms sensitive to the medicine:
— acute and chronic pharyngitis caused by beta-hemolytic Streptococcus A (as an alternative to treatment with beta-lactam antibiotics, especially in the case of contraindications to their use);
— acute sinusitis (given the sensitivity of the most common microorganisms that cause this pathology, the use of Rovamycin ® is indicated in the case of contraindications to the use of beta-lactam antibiotics);
— acute and chronic tonsillitis caused by microorganisms sensitive to spiramycin;
— acute bronchitis caused by a bacterial infection that developed after acute viral bronchitis;
— exacerbation of chronic bronchitis;
— community-acquired pneumonia in patients without risk factors for an adverse outcome, severe clinical symptoms and clinical signs of pneumococcal etiology of pneumonia;
— pneumonia caused by atypical pathogens (such as Chlamydia pneumoniae, Chlamydia trachomatis, Mycoplasma pneumoniae, Legionella spp.) or suspected (regardless of the severity and the presence or absence of risk factors for an adverse outcome);
— skin and subcutaneous tissue infections, including impetigo, impetigination, ectima, infectious dermohypodermitis (especially erysipelas), secondary infected dermatoses, erythrasma;
infection of the oral cavity (including stomatitis, glossitis);
— non-gonococcal infections of the genitals;
— toxoplasmosis, including during pregnancy;
— infections of the musculoskeletal system and connective tissue, including periodontitis.
Prevention of relapses of rheumatism in patients with Allergy to beta-lactam antibiotics.
Eradication of Neisseria meningitidis from the nasopharynx (with contraindications to taking rifampicin) for the prevention (but not treatment) of meningococcal meningitis: — in patients after treatment and before leaving quarantine;
— in patients who have been in contact with persons who have released Neisseria meningitidis with saliva into the environment for 10 days prior to hospitalization.
— glucose-6-phosphate dehydrogenase deficiency (risk of acute hemolysis);
— children's age (for 1.5 million tablets).IU - up to 6 years, for 3 million tablets.ME - up to 18 years old);
— hypersensitivity to the components of the drug.
With caution, Rovamycin ® is prescribed for bile duct obstruction, liver failure.
spiramycin 3 million IU.
Excipients: colloidal silicon dioxide - 2.4 mg, magnesium stearate - 8 mg, pre - gelatinized corn starch-32 mg, hyprolose - 16 mg, croscarmellose sodium - 16 mg, microcrystalline cellulose - up to 800 mg.
Shell composition: titanium dioxide (E171) - 2.96 mg, macrogol 6000 - 2.96 mg, hypromellose - 8.88 mg.
- Manufacturer: Sanofi-Aventis France